Inventor
Po-Ying Chan-Hui
Inventor
Bellevue, WA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides19%
C12NMicroorganisms or enzymes7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
Y10TTechnical subjects covered by former us classification4%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,865,234Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity202010,836,811Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody202010,407,493Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity201910,239,934Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity201910,087,239Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody20189,920,111'Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity'20189,464,131'Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody'20169,051,362'Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity'20158,822,651'Human rhinovirus (HRV) antibodies'20148,609,101'Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies'2013RE044437'Methods for detecting receptor complexes comprising PI3K'20138,247,180'Measuring receptor homodimerization'20127,648,828'Methods for detecting receptor complexes comprising PI3K'20107,402,399'Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy'20087,402,398'Measuring receptor homodimerization'20087,402,397'Detecting and profiling molecular complexes'20087,217,531'Multiplex analysis using membrane-bound sensitizers'20077,135,300'Profiling frequencies of receptor heterodimers'20067,122,319'Multiplexed immunohistochemical assays using molecular tags'20067,105,308'Detecting receptor oligomerization'20066,949,347'Multiplex analysis using membrane-bound sensitizers'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2012Based in Oakland, CA, US· patent location history
2006–2013Patents assigned to MONOGRAM BIOSCIENCES INC (9)· patent assignee history
2008Based in Mayne Island, CA· patent location history
2012–2015Patents assigned to CHAN-HUI PO-YING (5)· patent assignee history
2013–2020Patents assigned to THERACLONE SCIENCES INC (10)· patent assignee history
2013–2020Based in Bellevue, WA, US· patent location history
2015–2020Patents assigned to INT AIDS VACCINE INITIATIVE (8)· patent assignee history
2015–2020Patents assigned to SCRIPPS RESEARCH INST (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| THERACLONE SCIENCES INC | 10 | 2013–2020 |
| MONOGRAM BIOSCIENCES INC | 9 | 2006–2013 |
| INT AIDS VACCINE INITIATIVE | 8 | 2015–2020 |
| SCRIPPS RESEARCH INST | 8 | 2015–2020 |
| CHAN-HUI PO-YINGself | 5 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bellevue, Washington, US | 11 | 2013–2020 |
| Oakland, California, US | 9 | 2005–2012 |
| Mayne Island, CA | 1 | 2008 |